Linda Mattocks
Family · Mercer, PANPI 1124109947
Payments from drug & device makers
Across 99 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$443
- Novo Nordisk$291
- Pfizer$217
- Amgen$132
- Lilly USA, LLC$118
- Boehringer Ingelheim$80
- plus $512 from 20 others
What the payments were for
- Food & beverage$1,794100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $443 |
| Novo Nordisk | 14 | $291 |
| Pfizer | 11 | $217 |
| Amgen | 7 | $132 |
| Lilly USA, LLC | 7 | $118 |
| Boehringer Ingelheim | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Merck | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 2 | $42 |
| Amarin Pharma, Inc. | 2 | $39 |
| GSK | 2 | $37 |
| Astellas Pharma US Inc | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Exact Sciences | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Bayer | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Lundbeck LLC | 1 | $13 |
How this compares
$1,794 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $7,547 |
| Duloxetine Hcl | 29 | $2,261 |
| Pantoprazole Sodium | 14 | $782 |
| Quetiapine Fumarate | 25 | $495 |
| Digoxin | 12 | $289 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $244 |
| Levothyroxine Sodium | 31 | $238 |
| Lorazepam | 46 | $237 |
| Potassium Chloride | 53 | $230 |
| Simvastatin | 12 | $211 |
| Triamcinolone Acetonide | 15 | $197 |
| Tramadol Hcl | 29 | $145 |
| Citalopram HbrCitalopram Hydrobromide | 14 | $98 |
| Lisinopril | 13 | $98 |
| Fluoxetine Hcl | 14 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $217 | $7,54733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,717 family providers in Pennsylvania.
Other family in Mercer
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.